Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide

Scott R. Goldsmith; Michael Slade; John F. Dipersio; Peter Westervelt; Steven J. Lawrence; Geoffrey L. Uy; Camille N. Abboud; Ravi Vij; Mark A. Schroeder; Todd A. Fehniger; Erik R. Dubberke; Kathryn Trinkaus; Rizwan Romee

doi:10.3324/haematol.2016.149880

Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide

Scott R. Goldsmith, Michael Slade, John F. Dipersio, Peter Westervelt, Steven J. Lawrence, Geoffrey L. Uy, Camille N. Abboud, Ravi Vij, Mark A. Schroeder, Todd A. Fehniger, Erik R. Dubberke, Kathryn Trinkaus, Rizwan Romee

Research output: Contribution to journal › Letter › peer-review

36 Scopus citations

Original language	English
Pages (from-to)	e465-e468
Journal	Haematologica
Volume	101
Issue number	11
DOIs	https://doi.org/10.3324/haematol.2016.149880
State	Published - Oct 31 2016

Access to Document

10.3324/haematol.2016.149880

Cite this

Goldsmith, S. R., Slade, M., Dipersio, J. F., Westervelt, P., Lawrence, S. J., Uy, G. L., Abboud, C. N., Vij, R., Schroeder, M. A., Fehniger, T. A., Dubberke, E. R., Trinkaus, K., & Romee, R. (2016). Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide. Haematologica, 101(11), e465-e468. https://doi.org/10.3324/haematol.2016.149880

@article{e270765801754cf7a74eec56f58b9190,

title = "Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide",

author = "Goldsmith, {Scott R.} and Michael Slade and Dipersio, {John F.} and Peter Westervelt and Lawrence, {Steven J.} and Uy, {Geoffrey L.} and Abboud, {Camille N.} and Ravi Vij and Schroeder, {Mark A.} and Fehniger, {Todd A.} and Dubberke, {Erik R.} and Kathryn Trinkaus and Rizwan Romee",

note = "Funding Information: MS was supported by the Washington University Institute of Clinical and Translational Sciences grant UL1TR000448, sub-award TL1TR000449, from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official view of the NIH.",

year = "2016",

month = oct,

day = "31",

doi = "10.3324/haematol.2016.149880",

language = "English",

volume = "101",

pages = "e465--e468",

journal = "Haematologica",

issn = "0390-6078",

number = "11",

}

Goldsmith, SR, Slade, M, Dipersio, JF , Westervelt, P , Lawrence, SJ , Uy, GL , Abboud, CN , Vij, R , Schroeder, MA , Fehniger, TA , Dubberke, ER, Trinkaus, K & Romee, R 2016, 'Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide', Haematologica, vol. 101, no. 11, pp. e465-e468. https://doi.org/10.3324/haematol.2016.149880

Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide. / Goldsmith, Scott R.; Slade, Michael; Dipersio, John F. et al.

In: Haematologica, Vol. 101, No. 11, 31.10.2016, p. e465-e468.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide

AU - Goldsmith, Scott R.

AU - Slade, Michael

AU - Dipersio, John F.

AU - Westervelt, Peter

AU - Lawrence, Steven J.

AU - Uy, Geoffrey L.

AU - Abboud, Camille N.

AU - Vij, Ravi

AU - Schroeder, Mark A.

AU - Fehniger, Todd A.

AU - Dubberke, Erik R.

AU - Trinkaus, Kathryn

AU - Romee, Rizwan

N1 - Funding Information: MS was supported by the Washington University Institute of Clinical and Translational Sciences grant UL1TR000448, sub-award TL1TR000449, from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official view of the NIH.

PY - 2016/10/31

Y1 - 2016/10/31

UR - http://www.scopus.com/inward/record.url?scp=84994568494&partnerID=8YFLogxK

U2 - 10.3324/haematol.2016.149880

DO - 10.3324/haematol.2016.149880

M3 - Letter

C2 - 27443287

AN - SCOPUS:84994568494

VL - 101

SP - e465-e468

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 11

ER -

Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide

Access to Document

Other files and links

Cite this